HERLEV, Denmark , May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on ... Nordic_Bioscience.jpg Logo - https://mma.prnewswire.com ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

Roche currently has 13 manufacturing and 15 research and development sites in the country across pharmaceutical and ...

As part of this transformation, Roche Diagnostics – one of the world’s largest biotech companies and leading in-vitro diagnostics laboratory – is intensifying its engagement with Saudi Arabia.

“We are proud of our 110 year legacy in the United States which has been a key driver for jobs, innovation and the creation of intellectual property in the US, across both our Pharmaceutical and ...

Roche posted flat diagnostics sales in Q1 2025, impacted by recent healthcare pricing reforms in China. The big pharma company’s sales for diagnostic products totalled $4.2bn (CHF 3.5bn ...

Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV.

These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R&D sites across the Pharmaceutical and Diagnostics Divisions, and are expected to ...

Roche will add more than 12,000 new jobs as it grows its U.S. operations with new and upgraded production and research sites.

The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out ...

Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche ...

Roche currently has 13 manufacturing and 15 research and development sites in the country across pharmaceutical and diagnostics branches. One of the strategic goals for the company is to boost its ...